He amphoras that were found in 2006-2007 tralleis excavation

Karia kenti olan Tralleis, antik dönemde Batı Anadolu'da önemli bir yere sahipti. Hellenistik ve Roma Döneminde heykeltıraşlıktan başka, seramik alanında da öne çıktığı, yapılan çalışmalar ve ele geçen buluntulardan anlaşılmaktadır. Kentin Sigillata üretimi yaptığı antik kaynaklarda geçmektedir. Kazı çalışmalarındaki buluntular ile yapılan çalışmalar bunu kanıtlar niteliktedir. Şimdiye kadar detaylı bir şekilde incelenmeyen Tralleis amphoraları hakkında detaylı bilgiler edilmeye çalışılmıştır. 2006-2007 kazı çalışmalarında bulunan 141 adet amphora parçalarının ışığında kentin hangi tip amphoraları kullandığı ve amphora üretimindeki yeri belirlenmek istenmiştir. Hellenistik ve Roma Döneminde sevilerek kullanılan tiplerin örneklerine buluntular arasında da rastlamaktayız. En yoğun buluntumuz olan LR 3 tipi amphoralar üretildikleri yerlere göre farklı form özellikleri göstermektedir. Elimizdekilerle farklı bölge üretimi LR 3 amphoralarını karşılaştırıldığında, aynı form özelliğini göstermediğini görmekteyiz. Böylece Sigillata üretim merkezi olan kentin LR 3 tipini de üretmiş olması olasıdır.Tralleis which was a Karia city was an important place in the West Anatolia in ancient times.It has been understood that from the studies and foundlings it was led not only sculpture but also ceramics during Hellenistics and Rome times.It had been passed in the ancient resources that the city did the Sigillata production.The foundlings that were in diggings and the studies proved this.The Tralleis amphoras that weren?t examined detailly up to know and the detail knowledge has to be tried to find.During 2006-2007 Foundling studies amphoras were found and it was tried to determine which types of amphoras were used and what place was it at the production of the amphora. We see the examples of the foundlings that were used lovely during Hellenistics and Rome times.The most common foundlings are LR3 types of amphoras and they show the different specialities that were found place.When the amphoras we see that they can't show the same form speciality.So the city that was Sigillata production center had produced the LR3 type too

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN